| Immunomodulatory effects of lenvatinib plus anti–programmed cell death protein 1 in mice and rationale for patient enrichment in hepatocellular carcinoma L Torrens, C Montironi, M Puigvehí, A Mesropian, J Leslie, PK Haber, ... Hepatology 74 (5), 2652-2669, 2021 | 98 | 2021 |
| CXCR2 inhibition enables NASH-HCC immunotherapy J Leslie, JBG Mackey, T Jamieson, E Ramon-Gil, TM Drake, F Fercoq, ... Gut 71 (10), 2093-2106, 2022 | 88 | 2022 |
| Immunomodulatory effects of lenvatinib plus anti-PD1 in mice and rationale for patient enrichment in hepatocellular carcinoma L Torrens, C Montironi, M Puigvehí, A Mesropian, J Leslie, PK Haber, ... Hepatology (Baltimore, Md.), 2021 | 15 | 2021 |
| Key features of the environment promoting liver cancer in the absence of cirrhosis MYW Zaki, AK Mahdi, GL Patman, A Whitehead, JP Maurício, MV McCain, ... Scientific reports 11 (1), 16727, 2021 | 11 | 2021 |
| BlaDimiR: a urine-based miRNA score for accurate bladder cancer diagnosis and follow-up C Suarez-Cabrera, L Estudillo, E Ramón-Gil, M Martínez-Fernández, ... European urology 82 (6), 663-667, 2022 | 7 | 2022 |
| c‐Rel–dependent Chk2 signaling regulates the DNA damage response limiting hepatocarcinogenesis J Leslie, JE Hunter, A Collins, A Rushton, LG Russell, E Ramon‐Gil, ... Hepatology 78 (4), 1050-1063, 2023 | 3 | 2023 |
| ST3 beta-galactoside alpha-2, 3-sialyltransferase 1 (ST3Gal1) synthesis of Siglec ligands mediates anti-tumour immunity in prostate cancer R Garnham, D Geh, R Nelson, E Ramon-Gil, L Wilson, EN Schmidt, ... Communications Biology 7 (1), 276, 2024 | 2 | 2024 |
| Synthesis and preclinical evaluation of a 89Zr-labelled human single chain antibody for non-invasive detection of hepatic myofibroblasts in acute liver injury TA Pringle, E Ramon-Gil, J Leslie, F Oakley, MC Wright, JC Knight, S Luli Scientific Reports 14 (1), 633, 2024 | | 2024 |
| Novel and Non-invasive Tool for Immunotherapy-Response Prediction in Non-muscle-Invasive Bladder Cancer Patients Based on miRNAs and Cytokine Detection in Urine ÁM De Bernardo, E Ramón-Gil, MR Izquierdo, F Guerrero, D Castellano, ... The Journal of Liquid Biopsy 1, 2023 | | 2023 |
| Harnessing neutrophil plasticity for HCC immunotherapy E Ramon-Gil, D Geh, J Leslie Essays in Biochemistry 67 (6), 941-955, 2023 | | 2023 |
| Neutrophil degranulation and ageing as potential therapeutic targets in hepatocellular carcinoma? D Geh, ER Gil, M Laszczewska, A Collins, S Luli, R Cameron, F Oakley, ... Journal of Hepatology 78, S542, 2023 | | 2023 |
| Modelling hepatocellular carcinoma in precision-cut liver slices for therapeutic screening and as a precision medicine tool A Collins, J Leslie, D Geh, ER Gil, M Laszczewska, G Nelson, R Cameron, ... Journal of Hepatology 78, S565, 2023 | | 2023 |
| Immunotherapy resistance in NASH-HCC is driven by the dysfunctional liver microenvironment of NASH D Geh, ER Gil, M Laszczewska, A Collins, S Luli, R Cameron, F Oakley, ... Journal of Hepatology 78, S538-S539, 2023 | | 2023 |
| ST3Gal1 synthesis of Siglec ligands mediates anti-tumour immunity in prostate cancer R Garnham, D Geh, R Nelson, E Ramon-Gill, L Wilson, EN Schmidt, ... bioRxiv, 2023.04. 03.535346, 2023 | | 2023 |
| Hepatocellular carcinoma alters granulopoiesis to produce neutrophils with an immature phenotype D Geh, E Ramon-Gil, M Laszczewska, S Luli, R Cameron, A Collins, ... Immunology 21 (2), 135-44, 2020 | | 2020 |
